Proceedings of a Workshop Series
NATIONAL ACADEMIES PRESS 500 Fifth Street, NW Washington, DC 20001
This activity was supported by contracts and awards between the National Academy of Sciences and American Society of Tropical Medicine and Hygiene, Burroughs Wellcome Fund, Centers of Disease Control and Prevention (Contract No. 75D30121F00095), EcoHealth Alliance, ExxonMobil Foundation, Infectious Diseases Society of America, Johnson & Johnson (Contract No. C2021020002), Merck & Co., Inc., National Institute of Allergy and Infectious Diseases (Contract No. HHSN263201800029I, Task No. HHSN26300011), New Venture Fund (Contract No. NVF-NGDF-NAT10-Subgrant-017387-2022-04-01), Sanofi Pasteur, U.S. Agency for International Development (Grant No. 7200AA18GR00003), Uniformed Services University of Health Sciences (Award No. 5R13FD006897-03), U.S. Food and Drug Administration (Award No. 5R13FD006897-03), U.S. Department of Veterans Affairs (Contract No. 36C24518D0171). Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.
International Standard Book Number-13: 978-0-309-69767-5
International Standard Book Number-10: 0-309-69767-0
Digital Object Identifier: https://doi.org/10.17226/26833
This publication is available from the National Academies Press, 500 Fifth Street, NW, Keck 360, Washington, DC 20001; (800) 624-6242 or (202) 334-3313; http://www.nap.edu.
Copyright 2023 by the National Academy of Sciences. National Academies of Sciences, Engineering, and Medicine and National Academies Press and the graphical logos for each are all trademarks of the National Academy of Sciences. All rights reserved.
Printed in the United States of America.
Suggested citation: National Academies of Sciences, Engineering, and Medicine. 2023. The role of plant agricultural practices on development of antimicrobial resistant fungi affecting human health: Proceedings of a workshop. Washington, DC: The National Academies Press. https://doi.org/10.17226/26833.
The National Academy of Sciences was established in 1863 by an Act of Congress, signed by President Lincoln, as a private, nongovernmental institution to advise the nation on issues related to science and technology. Members are elected by their peers for outstanding contributions to research. Dr. Marcia McNutt is president.
The National Academy of Engineering was established in 1964 under the charter of the National Academy of Sciences to bring the practices of engineering to advising the nation. Members are elected by their peers for extraordinary contributions to engineering. Dr. John L. Anderson is president.
The National Academy of Medicine (formerly the Institute of Medicine) was established in 1970 under the charter of the National Academy of Sciences to advise the nation on medical and health issues. Members are elected by their peers for distinguished contributions to medicine and health. Dr. Victor J. Dzau is president.
The three Academies work together as the National Academies of Sciences, Engineering, and Medicine to provide independent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions. The National Academies also encourage education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science, engineering, and medicine.
Learn more about the National Academies of Sciences, Engineering, and Medicine at www.nationalacademies.org.
Consensus Study Reports published by the National Academies of Sciences, Engineering, and Medicine document the evidence-based consensus on the study’s statement of task by an authoring committee of experts. Reports typically include findings, conclusions, and recommendations based on information gathered by the committee and the committee’s deliberations. Each report has been subjected to a rigorous and independent peer-review process and it represents the position of the National Academies on the statement of task.
Proceedings published by the National Academies of Sciences, Engineering, and Medicine chronicle the presentations and discussions at a workshop, symposium, or other event convened by the National Academies. The statements and opinions contained in proceedings are those of the participants and are not endorsed by other participants, the planning committee, or the National Academies.
Rapid Expert Consultations published by the National Academies of Sciences, Engineering, and Medicine are authored by subject-matter experts on narrowly focused topics that can be supported by a body of evidence. The discussions contained in rapid expert consultations are considered those of the authors and do not contain policy recommendations. Rapid expert consultations are reviewed by the institution before release.
For information about other products and activities of the National Academies, please visit www.nationalacademies.org/about/whatwedo.
PLANNING COMMITTEE ON THE ROLE OF PLANT AGRICULTURAL PRACTICES ON DEVELOPMENT OF ANTIMICROBIAL RESISTANT FUNGI AFFECTING HUMAN HEALTH1
SALLY MILLER (Co-chair), Distinguished Professor of Food, Agricultural and Environmental Sciences in Plant Pathology, The Ohio State University
PAIGE WATERMAN (Co-chair), Professor of Medicine and Vice Chair of Clinical Research, Uniformed Services University of the Health Sciences
MARIN BREWER, Associate Professor, University of Georgia
TOM CHILLER, Chief, Mycotic Diseases Branch, U.S. Centers for Disease Control and Prevention
JULIUS FAJARDO, Senior Plant Pathologist, Office of Pest Management Policy, Office of Chief Economist, U.S. Department of Agriculture
SUSAN JENNINGS, Senior Advisor for Public Health, Office of Pesticide Programs, U.S. Environmental Protection Agency
RAMANAN LAXMINARAYAN, Director, One Health Trust
JEFFREY LEJEUNE, Food Safety Officer, Food Systems and Food Safety Division, Food and Agriculture Organization of the United Nations
MERVALIN MORANT, Program Manager, Food, Agriculture and Veterinary Defense, U.S. Department of Homeland Security
PHILIP TAYLOR, Training Manager and Global Plant Clinic Coordinator, CABI
Forum on Microbial Threats Staff
ELIZABETH ASHBY, Associate Program Officer
CLAIRE BIFFL, Research Assistant
CHARLES MINICUCCI, Research Assistant (until January 2023)
JUSTIN HAMMERBERG, Senior Program Assistant (until November 2022)
JULIE LIAO, Director, Forum on Microbial Threats
JULIE PAVLIN, Senior Board Director, Board on Global Health
___________________
1 The National Academies of Sciences, Engineering, and Medicine’s planning committees are solely responsible for organizing the workshop, identifying topics, and choosing speakers. The responsibility for the published Proceedings of a Workshop rests with the workshop rapporteurs and the institution.
This page intentionally left blank.
FORUM ON MICROBIAL THREATS1
PETER DASZAK (Chair), President, EcoHealth Alliance
KENT E. KESTER (Vice Chair), Vice President of Translational Medicine, International AIDS Vaccine Initiative
EMILY ABRAHAM, Director, External Affairs and Policy, Global Public Health at Johnson & Johnson
KEVIN ANDERSON, retired
CHRISTOPHER BRADEN, Acting Director, National Center for Emerging Zoonotic Infectious Diseases, U.S. Centers for Disease Control and Prevention
DANIEL BAUSCH, President, American Society of Tropical Medicine and Hygiene and Senior Director, Emerging Threats & Global Health Security, FIND
CRISTINA CASSETTI, Deputy Division Director, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
ANDREW CLEMENTS, Senior Scientific Advisor, Emerging Threats Division, U.S. Agency for International Development
MALICK DIARA, Public Health Manager, Corporate Medicine and Occupational Health Department, ExxonMobil
SCOTT F. DOWELL, Deputy Director for Surveillance and Epidemiology, Bill & Melinda Gates Foundation
MARCOS A. ESPINAL, Assistant Director, Pan American Health Organization
EVA HARRIS, Professor, Division of Infectious Diseases and Vaccinology, and Director, Center for Global Public Health, University of California, Berkeley School of Public Health
JON H. HEINRICHS, Associate Vice President and R&D New Targets, Franchise Head in Portfolio Strategy and Execution, Sanofi Pasteur
ELIZABETH D. HERMSEN, Lead, Global Antimicrobial Resistance & Antimicrobial Stewardship Medical Affairs, Pfizer
MARK G. KORTEPETER, Vice President for Research and Professor of Preventive Medicine and Medicine, Uniformed Services University of the Health Sciences
MICHAEL MAIR, Acting Assistant Commissioner for Counterterrorism Policy and Acting Director, Office of the Chief Scientist, U.S. Food and Drug Administration
___________________
1 The National Academies of Sciences, Engineering, and Medicine’s forums and roundtables do not issue, review, or approve individual documents. The responsibility for the published Proceedings of a Workshop rests with the workshop rapporteurs and the institution.
JONNA A. K. MAZET, Vice Provost—Grand Challenges; Chancellor’s Leadership Professor of Epidemiology & Disease Ecology, University of California, Davis
VICTORIA McGOVERN, Senior Program Officer, Burroughs Wellcome Fund
SALLY A. MILLER, Distinguished Professor of Food, Agricultural and Environmental Sciences in Plant Pathology, The Ohio State University College of Food, Agriculture, and Environmental Sciences
SUERIE MOON, Director of Research, Global Health Centre; Visiting Lecturer, graduate Institute of International and Development Studies; Adjunct Lecturer, Harvard T.H. Chan School of Public Health
RAFAEL OBREGÓN, Country Representative, UNICEF Paraguay
KUMANAN RASANATHAN, Unit Head for Equity and Health, Department of Social Determinants of Health, World Health Organization
GARY A. ROSELLE, Executive Director, National Infectious Disease Services Program, Veterans Health Administration, U.S. Department of Veterans Affairs
PETER A. SANDS, Executive Director, The Global Fund to Fight AIDS, Tuberculosis & Malaria
THOMAS W. SCOTT, Distinguished Professor, Department of Entomology and Nematology, University of California, Davis
MATTHEW ZAHN, Deputy Health Officer, Orange County Health Care Agency
National Academies of Sciences, Engineering, and Medicine Staff
ELIZABETH ASHBY, Associate Program Officer
CLAIRE BIFFL, Research Assistant
CHARLES MINICUCCI, Research Assistant (until January 2023)
JUSTIN HAMMERBERG, Senior Program Assistant (until November 2022)
JULIE LIAO, Director, Forum on Microbial Threats
JULIE PAVLIN, Senior Board Director, Board on Global Health
Reviewers
This Proceedings of a Workshop was reviewed in draft form by individuals chosen for their diverse perspectives and technical expertise. The purpose of this independent review is to provide candid and critical comments that will assist the National Academies of Sciences, Engineering, and Medicine in making each published proceedings as sound as possible and to ensure that it meets the institutional standards for quality, objectivity, evidence, and responsiveness to the charge. The review comments and draft manuscript remain confidential to protect the integrity of the process.
We thank the following individuals for their review of this proceedings:
Although the reviewers listed above provided many constructive comments and suggestions, they were not asked to endorse the content of the proceedings nor did they see the final draft before its release. The review of this proceedings was overseen by HUGH H. TILSON, University of North Carolina. He was responsible for making certain that an independent examination of this proceedings was carried out in accordance with standards of the National Academies and that all review comments were carefully considered. Responsibility for the final content rests entirely with the rapporteurs and the National Academies.
This page intentionally left blank.
Contents
Organization of the Proceedings of the Workshop
2 FUNGAL PATHOGENS IN PLANT AND HUMAN HEALTH
Antifungal Drug Uses in Human Medicine
Agricultural Chemical Use Statistical Program
Quadripartite Alliance Joint Activities on Antimicrobial Resistance
3 FUNGAL DISEASES, ANTIFUNGAL RESISTANCE, AND HUMAN HEALTH
Impact of Invasive Fungal Diseases and Antifungal Drug Resistance on Human Health
Global Incidence and Prevalence of Aspergillosis and Introduction to Azole Resistance
The Emerging Threat of Antifungal-Resistant Candida Species
Current Research on Pathogenesis and Host Immunity Toward Treatment Options
4 FUNGICIDE RESISTANCE IN PLANT PROTECTION USE
Genetics and Mechanisms of Fungicide Resistance
Azole-resistant Aspergillus fumigatus in Agronomic Settings: Hotspots and Coldspots
5 ROLE OF FUNGICIDE USE IN FOOD SAFETY AND SECURITY
Role of Azole Fungicides in Safeguarding Food Safety and Security
Azole Use for Food Safety and Security
6 DIMENSIONS OF FUNGICIDE REGULATIONS, USE MANAGEMENT, AND RISK ASSESSMENT
Use of Fungicides in Low- and Middle-Income Countries
U.S. Fungicide Regulation and Registration
Organisation for Economic Co-operation and Development Pesticides Programme
Occupational Exposure to Environmental Resistant Fungi and Possible Implications in Human Health
7 INNOVATIONS IN ANTIMICROBIAL RESISTANCE SURVEILLANCE TOOLS AND TECHNOLOGIES
Aspergillus fumigatus Azole Resistance Survey by Air Sampling Through a Community Science Approach
Impact Network Analysis for Guiding Surveillance and Mitigation
8 ONE HEALTH APPROACH TO ANTIMICROBIAL RESISTANCE AND PATHOGEN SURVEILLANCE
One Health Approach to Antimicrobial Resistance Surveillance and Mitigation Measures
International One Health Approach to Antimicrobial Resistance and Pathogen Surveillance
One Health Aspects of Circularity
9 ANTIFUNGAL DRUG DEVELOPMENT AND STEWARDSHIP IN HEALTH CARE
New Antifungal Drugs in Development
Antifungal Research and Development: Challenges and Need for Incentives
10 INTEGRATED PLANT DISEASE MANAGEMENT
Precision Application Technologies and Stakeholder Communication
Finding Needles in Haystacks: Disease Monitoring and Risk Assessment
This page intentionally left blank.
Boxes and Figures
BOXES
2-1 Strategic Framework for Collaboration on Antimicrobial Resistance
3-1 Hypothetical Case Study of Healthcare-Associated Candida Infection
FIGURES
2-1 Drivers of antimicrobial resistance
4-1 Resistance occurs to all classes of drugs used against plant and animal fungal infections
5-1 Comparative effect of fungicide seed treatment versus no treatment on peanut plant sprouting
6-1 Regional breakdown of azole fungicide use based on Plantwise data analysis
6-2 Occupational exposure versus development of fungal disease
6-3 Clinical implications of resistant Aspergillus spores
7-1 Mitigation and management strategies across the fungal pathogen life cycle
Acronyms and Abbreviations
ACT | AMR Codex Texts |
AFST | antifungal susceptibility testing |
AI | artificial intelligence |
AIRE | autoimmune regulator |
AMR | antimicrobial resistance |
AMU | antimicrobial use |
ARAf | azole-resistant Aspergillus fumigatus |
ARLN | Antimicrobial Resistance Laboratory Network |
ARS | Agricultural Research Service |
BARDA | Biomedical Advanced Research and Development Authority |
BTK | Bruton’s tyrosine kinase |
C5 | component 5 |
CABI | Centre for Agriculture and Bioscience International |
CARD9 | caspase recruitment domain family member 9 |
CBC | cap-binding complex |
CD4 | cluster of differentiation 4 |
CDC | Centers for Disease Control and Prevention |
CLABSI | central line-associated bloodstream infections |
CNS | central nervous system |
COPD | chronic obstructive pulmonary disease |
CPA | chronic pulmonary aspergillosis |
CYP51 | sterol 14-alpha-demethylase |
DHODH | dihydroorotate dehydrogenase |
DMI | demethylation inhibitor |
DON | deoxynivalenol |
EPA | Environmental Protection Agency |
FAO | Food and Agriculture Organization of the United Nations |
FDA | U.S. Food and Drug Administration |
FHB | Fusarium head blight |
FIFRA | Federal Insecticide, Fungicide, and Rodenticide Act |
FRAC | Fungicide Resistance Action Committee |
GAFFI | Global Action for Fungal Infections |
GLP | Principles of Good Laboratory Practice |
GM-CSF | granulocyte-macrophage colony-stimulating factor |
GPI | glycosyl-phosphatidyl inositol |
ICU | intensive care unit |
INA | impact network analysis |
InFARM | International FAO Antimicrobial Resistance Monitoring |
IPM | integrated pest management |
IUCLID | International Uniform Chemical Information Database |
JAK | Janus kinase |
LAC | Latin America and the Caribbean |
LAMMN | Latin American Medical Mycology Network |
LMIC | low- and middle-income country |
MALDI-TOF | matrix-assisted laser desorption/ionization time-of-flight |
MER | market entry reward |
MIC | minimum inhibitory concentration |
NASS | National Agricultural Statistics Service |
NIAID | National Institute of Allergy and Infectious Diseases |
NIH | National Institutes of Health |
NTM | nontuberculous mycobacteria |
OECD | Organisation for Economic Co-operation and Development |
OSU | The Ohio State University |
PCR | polymerase chain reaction |
PPE | personal protective equipment |
QJS | Quadripartite Joint Secretariat |
QoI | quinone outside inhibitor |
ROS | reactive oxygen species |
SA | South Asia |
SBI | sterol biosynthesis inhibitor |
SDHI | succinate dehydrogenase inhibitor |
SEA | Southeast Asia |
SNP | single nucleotide polymorphism |
SSA | Sub-Saharan Africa |
SYK | spleen tyrosine kinase |
TB | tuberculosis |
TISSA | Tripartite Integrated Surveillance System for Antimicrobial Resistance and Antimicrobial Use |
UN | United Nations |
UNEP | United Nations Environment Programme |
USDA | U.S. Department of Agriculture |
WHO | World Health Organization |
WOAH | World Organisation for Animal Health |
This page intentionally left blank.